Symbiomix Therapeutics LLC

Lupin buys US-based Symbiomix Therapeutics for $150 mn

Healthcare

11 October, 2017

Lupin buys US-based Symbiomix Therapeutics for $150 mn

Homegrown drugmaker Lupin Ltd has acquired US-based Symbiomix Therapeutics LLC for a cash consideration of $150 million (Rs 980 crore) ......

Most Popular

Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News